Dr. Zain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 Duarte Rd
Duarte, CA 91010Phone+1 626-256-4673
Education & Training
- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1996 - 1999
- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1995 - 1997
- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1994 - 1995
- Zucker School of Medicine at Hofstra/Northwell at Forest Hills HospitalResidency, Internal Medicine, 1989 - 1992
- Fatima Jinnah Medical CollegeClass of 1987
Certifications & Licensure
- CA State Medical License 2002 - 2025
- NY State Medical License 1994 - 2025
- CT State Medical License 2001 - 2003
- NC State Medical License 1992 - 2001
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Safety and Efficacy Study of a BTK Inhibitor in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma Start of enrollment: 2011 May 01
- Phase 1 Dose Finding Study of Belinostat for Treatment of Patients With Peripheral T-cell Lymphoma (PTCL) Start of enrollment: 2013 May 01
- Brentuximab Vedotin and Lenalidomide in Treating Patients With Relapsed or Refractory T-Cell Lymphomas Start of enrollment: 2019 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 38 citationsSafety and efficacy of navitoclax, a BCL-2 and BCL-XL inhibitor, in patients with relapsed or refractory lymphoid malignancies: results from a phase 2a study.Sven de Vos, John P. Leonard, Jonathan W. Friedberg, Jasmine Zain, Kieron Dunleavy
Leukemia & Lymphoma. 2021-03-21 - 13 citationsLong-Term Results of High-Dose Therapy and Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: Effectiveness of Maintenance Rituximab.Matthew Mei, Thai Cao, Lu Chen, Joo Y. Song, Tanya Siddiqi
Biology of Blood and Marrow Transplantation. 2017-11-01 - 44 citationsPhase I/Ib Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor in Patients with Relapsed/Refractory T-Cell LymphomaAuris Huen, Bradley M. Haverkos, Jasmine Zain, Ramchandren Radhakrishnan, Mary Jo Lechowicz
Cancers. 2020-08-15
Abstracts/Posters
- Long Term Outcomes of Patients with Aggressive T-Cell Non-Hodgkin Lymphoma Undergoing Allogeneic Stem Cell Transplantation: Retrospective Results from a Single CenterJasmine M. Zain, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Blinatumomab/Lenalidomide in Relapsed/Refractory Non-HodgkinÍs Lymphoma: A Phase I California Cancer Consortium Study of Safety, Efficacy and Immune Correlative AnalysisJasmine Zain, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Phase 1 Results of Anti-PD-Ligand 1 (Durvalumab) & Lenalidomide in Patients with Cutaneous T Cell Lymphoma and Correlation with Programmed Death Ligand 1 Expression an...Jasmine Zain, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Preliminary Results of the Stapled Peptide ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Two Phase IIa Dose Expansion Cohorts in Relapsed/Refractory TP53 Wild-Type ...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Pembrolizumab in Patients with Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL): Data from the Keynote-013 and Keynote-170 StudiesClinically Re...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- 6th Annual Conference On How The Experts Treat Hematologic MalignanciesCity of Hope, Santa Monica, California - 9/18/2013
Press Mentions
- City of Hope Doctors Present Research on First KRAS Inhibitor and CAR T Cell Therapy at ASCOMay 29th, 2019
- City of Hope Clinical and Laboratory Investigators Present New Research at the 60December 4th, 2018
Committees
- Co-Chair, CPRMC (Cancer Protocol Regulatory and Monitoring Committee), City of Hope National Medical Center 2017 - Present
- Member, CPRMC (Cancer Protocol Regulatory and Monitoring Committee), City of Hope National Medical Center 2016 - 2017
Professional Memberships
- American Society of HematologyMember
- American Society of OncologyMember
- Member
- American Society for Blood and Marrow TransplantationMember
- International Society of Cutaneous LymphomaMember
- Southwest Oncology GroupMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: